Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.
about
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivoMultiple myeloma associated with an Evan's syndromeHemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.Novel immunotherapiesMultiple myeloma presenting with autoimmune hemolytic anemiaLeishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleenEvidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand.Anemia in multiple myeloma: role of deregulated plasma cell apoptosis.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.Apoptotic mechanisms in the control of erythropoiesis.European Myeloma Network guidelines for the management of multiple myeloma-related complications.Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.TRAIL, caspases and maturation of normal and leukemic myeloid precursors.Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma.Iron in multiple myeloma.A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection.Autosomal Dominant Polycystic Disease is Associated with Depressed Levels of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.In-vitro functional phenotypes of plasma cell lines from patients with multiple myeloma.Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors.Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand.Iron deficiency in a male with multiple myeloma.Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.Autoimmune hemolytic anemia and hyperglobulinemia leading to the diagnosis of multiple myeloma.Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating
P2860
Q24685620-425BD563-BCAD-4AE6-A850-91E6ECEDA090Q33440109-4B15B616-EC6D-45AC-A1E2-6B58C1F4D87FQ33521267-4E2939DB-9901-4FE8-BFA8-72162614BCA2Q33696464-ECC41783-8FE9-4BD7-ABA0-D78745EBD090Q33822677-A378857A-895D-405F-B1BE-87B6586D6C6BQ34316416-4F1A213A-90E9-4262-BB44-708A2B79729EQ34637852-4667B417-5463-4C38-8546-A5994D041FF1Q34770132-3BD41E93-E6BA-4BFE-89D1-652361BA6219Q34980347-252133A7-3362-4D78-BFD7-0D03E63F260AQ35209364-D5053EB1-A19B-4911-8CD7-2C4255A4439EQ35669897-EE3358B5-F301-403F-8CDD-5295DAE6D9A8Q35811887-494E7FC3-B71B-418B-8935-ED0FBF4F6F44Q36115636-2B86AF88-4681-4674-87A4-70901F9B3FCAQ36286862-D0AE51AF-CC85-45C1-8F2B-F610A7FD38D5Q36590964-74EE715B-EAB3-4576-A251-EE959097FE8DQ36936723-ACA0B122-53CF-4048-B766-A023BEADF6DEQ37089777-AC32A4DC-65A3-4E3C-91A2-182CF9EFB764Q37240757-DB3FB493-99A3-4581-86F6-5EB5DC68DF5EQ37324272-902D4415-A861-4F17-BE50-407BBC376586Q37324586-630969B7-03BC-412F-8384-9E7E6915925BQ37567989-FA6DC2FE-6FBC-4C0C-ABC9-70672B8B5E98Q40125324-E2EE3B21-E7B9-4C85-91E0-B987C49E82B7Q40215805-E9EEFBA6-9B5D-4503-8830-996876C0F9DDQ40581023-2BDF2030-CADD-42C2-A198-EAA9A8D8E95AQ40603990-6B677A09-AB61-4543-814B-217E858215A6Q42584597-C241F2E9-5F81-40D3-B6F8-E5A12A6040F3Q44529294-956EC37D-3E1B-4FF0-9AFA-31BE204EC792Q47103286-853F46D1-37BD-4C81-85AA-976A6A54475DQ50543689-AE4815CD-975B-4D9B-AA4F-D8380D5414D7
P2860
Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Negative regulation of erythroblast maturation by Fas-L
@nl
Negative regulation of erythro ...... of anemia in multiple myeloma.
@en
type
label
Negative regulation of erythroblast maturation by Fas-L
@nl
Negative regulation of erythro ...... of anemia in multiple myeloma.
@en
prefLabel
Negative regulation of erythroblast maturation by Fas-L
@nl
Negative regulation of erythro ...... of anemia in multiple myeloma.
@en
P50
P356
P1433
P1476
Negative regulation of erythro ...... of anemia in multiple myeloma
@en
P2093
Franco Dammacco
P304
P356
10.1182/BLOOD.V99.4.1305
P407
P577
2002-02-01T00:00:00Z